Compare IDXX & KB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IDXX | KB |
|---|---|---|
| Founded | 1983 | 2008 |
| Country | United States | South Korea |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Commercial Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 43.6B | 36.4B |
| IPO Year | 1996 | 2008 |
| Metric | IDXX | KB |
|---|---|---|
| Price | $562.15 | $107.70 |
| Analyst Decision | Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $721.67 | N/A |
| AVG Volume (30 Days) | ★ 564.7K | 176.3K |
| Earning Date | 05-05-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 2.31% |
| EPS Growth | ★ 22.59 | N/A |
| EPS | ★ 3.47 | N/A |
| Revenue | ★ $4,303,702,000.00 | N/A |
| Revenue This Year | $10.88 | $18.22 |
| Revenue Next Year | $8.59 | $3.21 |
| P/E Ratio | $162.76 | ★ $9.90 |
| Revenue Growth | ★ 10.42 | N/A |
| 52 Week Low | $507.55 | $76.31 |
| 52 Week High | $769.98 | $119.71 |
| Indicator | IDXX | KB |
|---|---|---|
| Relative Strength Index (RSI) | 51.06 | 56.80 |
| Support Level | $550.28 | $105.51 |
| Resistance Level | $589.82 | $113.05 |
| Average True Range (ATR) | 15.41 | 2.28 |
| MACD | 2.25 | 0.39 |
| Stochastic Oscillator | 64.65 | 75.19 |
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.
KB Financial Group Inc. is a financial holding company in Korea. The company operations include Kookmin Bank, one of the commercial banks in Korea. The company's subsidiaries collectively engage in a broad range of businesses, including commercial banking, credit cards, asset management, non-life and life insurance, capital markets activities, and international banking and finance. The company's segments include the Banking business, Securities business, Non-life Insurance business, Credit card business, and Life Insurance business. The Group generates the majority of its revenue from the Banking business.